Accele Biopharma was formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies that have the potential to dramatically improve human healthcare, have strong commercial promise and have the potential for generating early proof of concept data.

To achieve this goal we have assembled an experienced management team, a group of sophisticated investors, a nationally recognized advisory board, excellent research facilities and the broad scientific expertise necessary to evaluate and manage such opportunities.

  • Capital-efficient vehicle for emerging biotech investment

  • Experienced management team

  • Nationally recognized advisors

  • Excellent research and development facilities

  • Access to broad scientific expertise

  • Milestone-based development

Accele BioPharma Management Team

Accele BioPharma – Board of Directors

Accele Venture Partners – Board of Advisors

For more information about Accele or our portfolio companies: Contact Us